Literature DB >> 12974918

N-acetylcysteine in the treatment of non-alcoholic steatohepatitis.

Gülsüm Emel Pamuk, Abdullah Sonsuz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12974918     DOI： 10.1046/j.1440-1746.2003.03156.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  19 in total

1.  Glutathione!

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2014-02

Review 2.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

3.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

4.  Current and novel therapies for the treatment of nonalcoholic steatohepatitis.

Authors:  David van der Poorten; Jacob George
Journal:  Hepatol Int       Date:  2007-07-26       Impact factor: 6.047

Review 5.  Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Geyza Nogueira de Almeida Armiliato; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-03-27

6.  Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis.

Authors:  Veysel Tahan; Fatih Eren; Erol Avsar; Dilek Yavuz; Meral Yuksel; Ebru Emekli; Nese Imeryuz; Cigdem Celikel; Hafize Uzun; Goncagul Haklar; Nurdan Tozun
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 7.  Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-27       Impact factor: 2.192

Review 8.  Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Juan Du; Yan-Yan Ma; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 9.  Molecular mechanisms involved in NAFLD progression.

Authors:  Mariano Malaguarnera; Michelino Di Rosa; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2009-04-08       Impact factor: 4.599

10.  Current treatments in nonalcoholic steatohepatitis.

Authors:  Dawn M Torres; Stephen A Harrison
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.